Intraperitoneal recombinant interferongamma in ovarian cancer patients with residual disease at second look laparotomy

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

1985 • 410 citations

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

1991 • 194 citations

Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.

1991 • 186 citations

Gamma-interferon inhibits collagen synthesis in vivo in the mouse.

1987 • 181 citations

Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.

1986 • 139 citations

Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I.

1982 • 112 citations

Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.

1987 • 94 citations

Intraperitoneal Administration of Interleukin-2 in Patients With Cancer

1986 • 91 citations

Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice

1986 • 88 citations

Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells.

1986 • 87 citations

Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration

1988 • 84 citations

Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy

1992 • 79 citations

Interferon-α and interferon-γ reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture

1988 • 65 citations

Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.

1988 • 62 citations

Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.

1990 • 61 citations

Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer

1990 • 61 citations

A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma.

1988 • 58 citations

Intraperitoneal administration of interferon β in ovarian cancer patients

1985 • 54 citations

Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin‐2 activated killer cells and by activated monocytes

1987 • 54 citations

Intraperitoneal chemotherapy in the management of ovarian cancer

1993 • 54 citations

Interferon-γ is required in activation of macrophages for tumor cytotoxicity

1983 • 53 citations

A phase I–II trial of intraperitoneal cisplatin and α-lnterferon in patients with persistent epithelial ovarian cancer

1990 • 47 citations

Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma.

1991 • 45 citations

Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum

1985 • 42 citations

Effectiveness of routine and spontaneous follow-up visits for breast cancer

1989 • 41 citations

Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon‐gamma

1988 • 36 citations

Ovarian Malignancies–Diagnostic and Therapeutic Advances

1988 • 28 citations

Proliferative and antiproliferative effects of interferon-'Y and tumor necrosis factor-α. on cell lines derived from cervical and ovarian malignancies

1990 • 26 citations

Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay

1987 • 12 citations

Differential Efficacies of Recombinant Murine Interferon-γ and Recombinant Human Interleukin 2 Against EL4-Bearing Mice

1988 • 6 citations